1. Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov
   Eric Wen Su et al, 2017 CrossRef
2. Telmisartan induces osteosarcoma cells growth inhibition and apoptosis via suppressing mTOR pathway
   Chao Wang et al, 2018 CrossRef
3. Telmisartan Influences the Antiproliferative Activity of Linoleic Acid in Human Colon Cancer Cells
   Magdalena Mielczarek-Puta et al, 2019, Nutrition and Cancer CrossRef
4. Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions
   Anca Nenicu et al, 2017, British Journal of Pharmacology CrossRef
5. Antihypertensive Drug Use and the Risk of Ovarian Cancer Death among Finnish Ovarian Cancer Patients—A Nationwide Cohort Study
   Eerik E. E. Santala et al, 2021, Cancers CrossRef
6. Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver
   Anuradha Pandit et al, 2022, Front. Oncol. CrossRef
7. Repurposed Drugs in Gastric Cancer
   Diana Araújo et al, 2022, Molecules CrossRef
8. Pharmacological Utility of PPAR Modulation for Angiogenesis in Cardiovascular Disease
   Nicole Wagner et al, 2023, IJMS CrossRef
9. Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp
   Mohamad Ali Hijazi et al, 2023, Cancers CrossRef
10. Dual function of activated PPARγ by ligands on tumor growth and immunotherapy
    Mingjun Chen et al, 2024, Med Oncol CrossRef
11. Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo.
    Takanori Matsui et al, 2019, Int J Mol Sci CrossRef
12. Expanding telmisartan’s therapeutic horizon: exploring its multifaceted mechanisms beyond cardiovascular disorders
    Yogesh S. Ahire et al, 2024, Futur J Pharm Sci CrossRef
13. Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics
    Anjana Sajeev et al, 2024, Front. Oncol. CrossRef